BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  STERIS to Host a Conference Call for Fiscal 2022 Second Quarter Financial Results on November 3, 2021

  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 second quarter financial results at 10:00 a.m. ET on November 3, 2021.

  October 20, 2021

   · 

  7 min read
• Business

  Theravance Biopharma to Report Third Quarter 2021 Financial Results November 3, 2021

  Theravance Biopharma, Inc. (NASDAQ: TBPH), will report its third quarter 2021 financial results and provide a business update after market close on Wednesday, November 3, 2021

  October 20, 2021

   · 

  2 min read
• UCB to license its AI technology that improves identification of Osteoporosis to ImageBiopsy Lab

  UCB today – on World Osteoporosis Day 2021 – announced a strategic out-licensing of Artificial Intelligence (AI) based fracture identification technology, BoneBot, to ImageBiopsy Lab to bring the new identification tool to clinical practice by 2023.

  October 20, 2021

   · 

  7 min read
• Business

  Elevation Oncology Announces the Promotion of Valerie Malyvanh Jansen, M.D., Ph.D., to Chief Medical Officer

  Elevation Oncology, Inc. today announced the appointment of Valerie M. Jansen , M.D., Ph.D., as Chief Medical Officer. Dr. Jansen was promoted from her prior role as Vice President

  October 20, 2021

   · 

  5 min read
• Biotech Beach

  Edwards Lifesciences To Host Earnings Conference Call On October 27, 2021

  Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2021 after the market closes on Wednesday, October 27, 2021 , and will host a conference call at 5:00 p.m. ET that day to discuss those results.

  October 20, 2021

   · 

  1 min read
• Genetown

  Stealth BioTherapeutics Receives Refusal to File Letter from the FDA

  Stealth BioTherapeutics Corp today announced that it received a Refusal to File letter from the United States Food and Drug Administration (FDA) regarding Stealth’s New Drug Application (NDA) for elamipretide, a mitochondria-targeted therapy for the treatment of Barth syndrome.

  October 20, 2021

   · 

  6 min read
• Drug Development

  Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product

  Numinus Wellness Inc. is pleased to have finalized the study design and protocol for a Phase 1 clinical trial on a naturally derived Psilocybin extract

  October 20, 2021

   · 

  5 min read
• Business

  Marc Schneebaum Joins Avalyn Pharma as Chief Financial Officer

  Avalyn Pharma Inc., a biopharmaceutical company focused on development of improved therapies for life threatening pulmonary diseases, announced that Marc Schneebaum has joined the company as Chief Financial Officer.

  October 20, 2021

   · 

  4 min read
• BioCapital

  Aditxt to Present at the Dawson James 6th Annual Small Cap Growth Conference in Florida on October 21, 2021

  Aditxt to Present at the Dawson James 6 th Annual Small Cap Growth Conference in Florida on October 21, 2021

  October 20, 2021

   · 

  2 min read
• Business

  Aptinyx Appoints Gilmore O’Neill, M.B., M.M.Sc., to Board of Directors

  Aptinyx Inc. today announced the appointment of Gilmore O’Neill, M.B., M.M.Sc., to the company’s board of directors.

  October 20, 2021

   · 

  4 min read